Serum miR-29a as a marker of multiple myeloma

Leukemia and Lymphoma

Volumn 54, Issue 1, 2013, Pages 189-191

  Sevcikova, Sabina ^a   Kubiczkova, Lenka ^a   Sedlarikova, Lenka ^a   Slaby, Ondrej ^b   Hajek, Roman ^a,c  

^a MASARYK UNIVERSITY   (Czech Republic)

^b MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

^c UNIVERSITY HOSPITAL BRNO   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 142 5P; MICRORNA 29A; MICRORNA 410; MICRORNA 660; UNCLASSIFIED DRUG;

AGE; AREA UNDER THE CURVE; CALCULATION; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER REGRESSION; CELL POPULATION; CELL PROLIFERATION; CORRELATION COEFFICIENT; HEMATOPOIESIS; HUMAN; LETTER; MOLECULARLY TARGETED THERAPY; MULTIPLE MYELOMA; PLASMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; MULTIPLE MYELOMA; NEOPLASM STAGING; TUMOR MARKERS, BIOLOGICAL;

EID: 84870938377     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2012.704030     Document Type: Letter

References (12)

1. H unter MP, I smail N, Z hang X, et al. D etection of microRNA expression in human peripheral blood microvesicles. PLoS One 2008; 3: E3694.
2. Chen X, Ba Y, Ma L, et al. Characterization of microRNAs in serum. Cell Res 2008; 18: 997- 1006.
3. N g EK, C hong WW, J in H, et al. D iff erential expression of microRNAs in plasma of patients with colorectal cancer. Gut 2009 ; 58: 1375-1381.
4. Redova M., Poprach A., Nekvindova J, et al. Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma. J Transl Med 2012; 10: 55.
5. H ajek R, K rejci M, P our L, et al. M ultiple myeloma. K lin Onkol 2011;24(Suppl.): S10- S13.
6. Anderson KC, Carrasco RD. Pathology of myeloma. Annu Rev Pathol Mech Dis 2011 ; 6: 249-274.
7. Gattolliat CH, Thomas L, Ciafr è SA, et al. Expression of miR-487b and miR-410 encoded by 14q32.31 locus is a prognostic marker in neuroblastoma. Br J Cancer 2011 ; 105: 1352-1361.
8. Chi J, Ballabio E, Chen XH, et al. MicroRNA expression in multiple myeloma is associated with genetic subtype, isotype and survival. Biol Direct 2011; 6: 23.
9. Pichiorri F, Suh SS, Ladetto M, et al. MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis. Proc Natl Acad Sci USA 2008 ; 105: 12885-12890.
10. Zhao H, Shen J, Medico L, et al. A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer. PLoS One 2010; 5: E13735.
11. Hu Z, Chen X, Zhao Y, et al. Serum microRNA signatures identifi ed in a genome-wide serum microRNA expression profi ling predict survival of non-small-cell lung cancer. J Clin Oncol 2010; 28: 1721- 1726.
12. Reid G, Kirschner MB, van Zandwijk N. Circulating microRNAs: Association with disease and potential use as biomarkers. Crit Rev Oncol Hematol 2011 ; 80: 193-208.